CMV Vaccine Study

Principal Investigator(s):Dr. Marcel Curlin
Objective:The purpose of this study is to find out the proportion of adults in the Portland area positive for a common virus called cytomegalovirus. This information is important to prepare for a future study where cytomegalovirus makes up part of an experimental vaccine to prevent HIV or tuberculosis.
Prevention Option(s):HIV Vaccine
Study Design:
Official Code: CMV Vaccine Study
Start Date
End Date
July 1, 2017
June 1, 2020
Age range: ↔ any